IHI's Holdings Could Mean 10% Gain PotentialBy Dividend Channel Staff, Friday, January 5, 10:44 AM ETLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares U.S. Medical Devices ETF (NYSE:IHI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $58.55 per unit. With IHI trading at a recent price near $53.22 per unit, that means that analysts see 10.02% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IHI's underlying holdings with notable upside to their analyst target prices are Treace Medical Concepts Inc (NASDAQ:TMCI), iRhythm Technologies Inc (NASDAQ:IRTC), and SI-BONE Inc (NASDAQ:SIBN). Although TMCI has traded at a recent price of $11.58/share, the average analyst target is 34.46% higher at $15.57/share. Similarly, IRTC has 23.29% upside from the recent share price of $100.25 if the average analyst target price of $123.60/share is reached, and analysts on average are expecting SIBN to reach a target price of $25.29/share, which is 22.80% above the recent price of $20.59. Below is a twelve month price history chart comparing the stock performance of TMCI, IRTC, and SIBN:
Below is a summary table of the current analyst target prices discussed above:
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research. The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
This Article's Word Cloud:
Analyst
BONE
Below
Concepts
Devices
ETFs
FREEGet
IRTC
Medical
SIBN
TMCI
Target
Technologies
Treace
Upside
With
Zacks
about
above
analyst
analysts
average
background
based
border
bottom
color
data
font
from
have
hctblstyle
holdings
iRhythm
iShares
implied
latest
mdash
month
price
recent
report
research
share
target
targets
that
trading
underlying
upside
|